vaccine assignment final

Upload: victor-gan

Post on 02-Jun-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/11/2019 Vaccine Assignment Final

    1/11

    London School of Hygiene & Tropical Medicine

    Distance Learning Assignment Cover Sheet

    This is a blank cover sheet for your assignment. Please complete ONE cover sheet for eachassignment. Please insert the requested information about your assignment in the column on the rightin the table below. You should then type or insert the corresponding assignment after this cover sheetpage and upload the full document to the online ssignment !anagement "ystem #!"$.

    Title of course for which you areregistered

    "tudent reference number

    !odule code #and section no. if% & e.g. '(!)*+.)$

    !odule title

    "oftware used

    ,ord count

    Total number of pages #notincluding cover sheet$

    re you re&sitting the assignmentfor this module-

    Yes or No #please state here$

    IMPOTA!T

    Only one assignment can be uploaded with each ssignment /over "heet.

    Please include cover sheet at the beginning of your assignment document.

    You will need to read and accept the online plagiarism declaration on your initial login before

    being able to upload your assignment#s$.

    Ensure that you have read and adhered to the guidance on referencing provided in the

    "tudent 0andbook.

    Please start your assignment on the ne1t page.

    0

  • 8/11/2019 Vaccine Assignment Final

    2/11

    Is it theoretically possible to generate a vaccine that is more

    efective at inducing protective immunity than the inection

    itself?

    Immunity as evolutionary contest between pathogen and hostThe ecological interaction between infectious pathogen and host is one where

    the pathogens evolutionary goal is continued reproduction. Many infections result in

    complete elimination of pathogen with subsequent lifelong immunity against

    reinfection. Evolutionary considerations may suggest that natural immunity has been

    optimized over long periods and articial vaccines are likely to be inferior. The second

    category includes diseases and vaccines under consideration in this essay namely

    those in which the immune system is either unable to fully eliminate primary

    infection or is unable to prevent subsequent reinfection of the same species of

    infectious agent through immunological memory. This limitation of protective

    immunity allows a theoretical possibility of designing a vaccine to provide greater

    e!cacy at inducing protective immunity than natural infection.

    Epidemiological evidence

    "ssessing natural immunity compared to vaccine#mediated immunity is by nomeans simple. "side from challenge e$periments which are an ethical quagmire the

    ne$t best estimates would come from epidemiological surveys. True estimates would

    require large samples including adequate unvaccinated cases problematic for diseases

    with widespread vaccine coverage in order to pick up rare cases of actual infection.

    %urther detailed lifelong histories together with laboratory conrmed status of past

    infection &including ideally molecular typing and serological correlates' would be

    necessary to compare against vaccination histories if possible along with e$posure

    histories. %or many diseases based on limited evidence there is a widespread

    understanding that natural immunity is better than vaccine#mediated immunity (.

    )nfortunately this is dependent on surveillance for repeat infections which is of a

    di*erent quality in the pre#vaccination era compared to the present.

    (+%requently "sked ,uestions # -accination # Ministre de /a 0ant1 et 2es 0ervices 0ociau$

    https344www.msss.gouv.qc.ca4su5ets4santepub4vaccination4inde$.php6foire7au$7questions7en8q(9

    :accessed ;< March =? +@eneral -accine 0afety Aoncerns B The Ahildrens Cospital of

    Dhiladelphia http344www.chop.edu4service4vaccine#education#center4vaccine#safety4general#safety#

    concerns.html8natural#infection :accessed ;< March =.

  • 8/11/2019 Vaccine Assignment Final

    3/11

    Tetanus may provide the strongest e$ample for the possibility of better vaccine#

    mediated immunity than natural immunity using epidemiological evidence while

    comparing to a well#described e$ample of where natural immunity is usually said to

    be better than vaccine#mediated immunity namely varicella. %or tetanus received

    wisdom is that infection does not confer immunityF =. 0eries of repeated infections

    have been reported;. Grreversible binding and rapid sequestration of the tetanus to$in

    tetanospasmin into neurons may be responsible for the short e$posure of the to$in to

    the immune system and thus minimizing time for generation of an adaptive immune

    response. Together with the small doses required for a severe oHten fatal clinical

    course few people develop antibodies as serosurveys in non#immunized populations

    have shown9. Gn contrast the formaldehyde treated tetanus to$oid has a virtually

    (

  • 8/11/2019 Vaccine Assignment Final

    4/11

    demonstrates the very high rate of natural immunity. Gn contrast clinical e!cacy of

    the varicella vaccine has been reported in a meta#analysis at Q9.LI &LI AG 99#(

  • 8/11/2019 Vaccine Assignment Final

    5/11

    Th+ vs Th, responses

    Xne classic e$ample of a pathogen biasing the TC(3TC= response ratio is in

    leishmaniasis where di*use cutaneous leishmaniasis is one manifestation of a bias to

    a A29 &Th=' dominated response with a lack of e!cient A2Q#mediated &Th(' killing of

    parasites. Drotective immunity is thus limited in this more chronic form of infection.

    "ttempts have been made to induce a Th( bias in the response when using vaccine

    approaches including live attenuated killed and antigen#based methods by utilising

    WA@ as an ad5uvant to enhance A2Q &ie TC(' response(

  • 8/11/2019 Vaccine Assignment Final

    6/11

    antigen ( &/0"#(' the only P falciparumantigen e$pressed e$clusively by hepatocytes in

    vaccination strategies by presenting it outside the tolerogenic environment of the

    liver in order to stimulate the immune system into acting against liver#stage parasites

    over and above the level of protective immunity generated by natural infection (L.

    .ranuloma formation

    Xrganisms may subvert natural protective immunity through stimulating

    immunopathologic responses that serve to evade host defences. @ranuloma formation

    by pathogens in the)ycobacterium tuberculosis&)tb' comple$ demonstrates this. )pon

    initial infection inZammatory reaction oHten leads to a granuloma containing

    dormant mycobacteria that are inaccessible to elimination by the immune system(N.Gt

    can be conceived that vaccines leading to sterile eradication of )tbcan be designed

    that overcome the suboptimal natural immunity leading to latent infection. Vaufmann

    suggests a vaccine strategy of stimulating di*erent T cell populations that can in

    concert eliminate latent)tb3 chemoattractant Th(O cells Th( cells that activate

    macrophages cytoto$ic A2Q T cells that attack intracellular )tb and antibodies to

    opsonize released)tb(O.

    Host life stage-dependent immune status

    /elative infantile immunode$iciency

    " few infections are prominent in neonates and infants among them

    0aemophilus in$luen*aetype W &0ib' which is encapsulated and for which immunity is

    dependent on a thymus#independent polysaccharide antigen (Q. )nder = years of age

    the immune system is not su!ciently matured to naturally resist invasive infection by

    0ib thus causing high rates of morbidity and mortality in this age group(. The recent

    (9Gan S. Arispe and others +Aellular and Molecular Mechanisms of /iver Tolerance Immunological

    /evie's =(; &=

  • 8/11/2019 Vaccine Assignment Final

    7/11

    use of a con5ugated vaccine &with diphtheria or tetanus to$oid' enhances

    immunogenicity in this age group over that of natural infection leading to protection

    against invasive disease=

  • 8/11/2019 Vaccine Assignment Final

    8/11

    salivary antigens enhancing protective immunity over and above that of natural

    infection=N.

    Tissue-speci$ic life-stages

    0chistosomes infect humans via the skin as cercarial larvae transiting throughthe skin as schistosomlae before maturing to adult worms with associated

    immunopathology. epeated infections are common which indicates that adaptive

    immunity against larval forms is not e*ective. Xne mechanism by which cercariae

    avoid stimulating the immune system is by secretion of immune modulators

    including prostaglandins which inhibit antigen#presentation by /angerhans cells in

    the skin=O.The increased e!cacy of irradiated cercariae in inducing protective

    immune in mouse models=Qdemonstrates how articial vaccine formulations focusing

    on particular parasite life#stages may improve on natural immunity.

    ConclusionThis essays aims to demonstrate that not only is it theoretically possible but

    given denitional constraints vaccine#mediated immunity has already surpassed

    natural immunity in a few cases by epidemiologic and immunologic criteria. Woth

    clinical endpoints and immune correlates such as seroconversion have been used in

    the discussion. %urther theoretical e$tensions to the principle have been proposedwithin a typology of compromised natural immune responses and suggestions of

    potential vaccine strategies made.

    =N/ukasz Vedzierski +/eishmaniasis -accine3 Uhere "re Ue Today6Journal of .lobal Infectious

    iseases = &=

  • 8/11/2019 Vaccine Assignment Final

    9/11

    References"bendroth "llison and "nn M. "rvin +Gmmune Evasion as a Dathogenic Mechanism of

    -aricella Yoster -irus %eminars in Immunology (; &=

  • 8/11/2019 Vaccine Assignment Final

    10/11

    avindran a5esh 0udipta Whowmick "mrita 2as and Sahid "li +Aomparison of WA@ MD/

    and Aationic /iposome "d5uvant 0ystems in /eishmanial "ntigen -accine %ormulations

    against Murine -isceral /eishmaniasis B)! )icrobiology (< &=

  • 8/11/2019 Vaccine Assignment Final

    11/11

    9